Invited Article: Nervous system pathology in sporadic Parkinson disease

Neurology

Volumn 70, Issue 20, 2008, Pages 1916-1925

  Braak, Heiko ^a   Del Tredici, Kelly ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTOPATHOLOGY; HUMAN; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW;

EID: 43649106356     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000312279.49272.9f     Document Type: Article

References (76)

1. LML de Lau MMB Breteler Epidemiology of Parkinson’s disease Lancet Neurol 5 2006 525 535
2. KA Jellinger Pathology of Parkinson’s disease. Changes other than the nigrostriatal pathway Molec Chem Neuropathol 14 1991 153 197
3. AE Lang AM Lozano Parkinson’s disease N Engl J Med 339 1998 1044 1053 1130-1143
4. H Takahashi K Wakabayashi The cellular pathology of Parkinson’s disease Neuropathology 21 2001 315 322
5. AE Lang JA Obeso Challenges in Parkinson’s disease: restoration of the nigrostriatal dopamine system is not enough Lancet Neurol 3 2004 309 316
6. JE Ahlskog Challenging conventional wisdom: the etiologic role of dopamine oxidative stress in Parkinson’s disease Mov Disord 20 2005 271 282
7. JW Langston The Parkinson’s complex: parkinsonism is just the tip of the iceberg Ann Neurol 59 2006 591 596
8. I Litvan G Halliday M Hallett The etiopathogenesis of Parkinson’s disease and suggestions for further research J Neuropathol Exp Neurol 66 2007 251 257
9. S Fahn Description of Parkinson’s disease as a clinical syndrome Ann NY Acad Sci 991 2003 1 14
10. K Kosaka Diffuse Lewy body disease Neuropathol 20 2000 73 78
11. CE Lippa JE Duda M Grossman DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers Neurology 68 2007 812 819
12. IG McKeith DW Dickson J Lowe Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium Neurology 65 2005 1863 1872
13. AJ Harding GM Halliday Cortical Lewy body pathology in the diagnosis of dementia Acta Neuropathol 102 2001 355 363
14. IH Richard M Papka A Rubio R Kurlan Parkinson’s disease and dementia with Lewy bodies: one disease or two? Mov Disord 17 2002 1161 1165
15. C Colosimo AJ Hughes L Kilford AJ Lees Lewy body cortical involvement may not always predict dementia in Parkinson’s disease J Neurol Neurosurg Psychiatry 74 2003 852 856
16. D Aarsland CG Ballard G Halliday Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17 2004 137 145
17. JE Galvin J Pollack JC Morris Clinical phenotype of Parkinson disease dementia Neurology 67 2006 1605 1611
18. K Wakabayashi K Tanji F Mori H Takahashi The Lewy body in Parkinson’s disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates Neuropathology 27 2007 494 506
19. JE Duda VMY Lee JQ Trojanowski Neuropathology of synuclein aggregates: new insights into mechanism of neurodegenerative diseases J Neurosci Res 61 2000 121 127
20. DW Dickson α-Synuclein and the Lewy body disorders Curr Opinion Neurol 14 2001 423 432
21. M Goedert The significance of tau and α-synuclein inclusions in neurodegenerative diseases Curr Opin Genet Develop 11 2001 343 351
22. E Kuusisto L Parkkinen I Alafuzoff Morphogenesis of Lewy bodies: dissimilar incorporation of α-synuclein, ubiquitin, and p62 J Neuropathol Exp Neurol 62 2003 1241 1253
23. I Mikolaenko O Pletnikova CH Kawas Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA) J Neuropath Exp Neurol 64 2005 156 162
24. GK Tofaris MG Spillantini Physiological and pathological properties of alpha-synuclein Cell Life Mol Sci 64 2007 2914 2201
25. JE Galvin VMY Lee JQ Trojanowski Synucleinopathies. Clinical and pathological implications Arch Neurol 58 2001 186 190
26. H Braak K Del Tredici U Rüb RAI de Vos ENH Jansen Steur E Braak Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 24 2003 197 211
27. LS Forno Concentric hyalin intraneuronal inclusions of Lewy type in the brain of elderly persons (50 incidental cases): relationship to parkinsonism J Am Geriatr Soc 17 1969 557 575
28. K Del Tredici U Rüb RAI de Vos JRE Bohl H Braak Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61 2002 413 426
29. A Bloch A Probst H Bissig H Adams M Tolnay α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects Neuropathol Appl Neurobiol 12 2006 284 295
30. GW Ross RD Abbott H Petrovitch Association of olfactory dysfunction with incidental Lewy bodies Mov Disord 21 2006 2062 2067
31. RD Abbott GW Ross H Petrovitch Bowel movement frequency in late-life and incidental Lewy bodies Mov Disord 22 2007 1581 1586
32. KA Jellinger Lewy-body-related α-synucleinopathy in the aged human brain J Neural Transm 111 2004 1219 1235
33. Y Saito NN Ruberu M Sawabe Lewy body-related α-synucleinopathy in aging J Neuropathol Exp Neurol 63 2004 742 749
34. K Iwanaga K Wakabayashi M Yoshimoto Lewy body-type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body disease Neurology 52 1999 1269 1271
35. WRG Gibb AJ Lees The significance of the Lewy body in the diagnosis of idiopathic Parkinson’s disease Neuropathol Appl Neurobiol 15 1989 27 44
36. Y Chu JH Kordower Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson’s disease? Neurobiol Dis 25 2007 134 149
37. TG Beach CH Adler LI Sue Reduced striatal tyrosine hydroxylase in incidental Lewy body disease Acta Neuropathol 115 2007 445 451
38. DW Dickson H Fujishiro A DelleDonne Evidence that incidental Lewy body disease is presymptomatic Parkinson’s disease Acta Neuropathol 115 2008 437 444
39. SE Daniel CH Hawkes Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology Lancet 340 1992 186
40. H Braak RAI de Vos J Bohl K Del Tredici Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology Neurosci Lett 396 2006 67 72
41. KJ Klos JE Ahlskog KA Josephs α-Synuclein pathology in the spinal cord of neurologically asymptomatic aged individuals Neurology 66 2006 1100 1102
42. H Braak M Sastre JRE Bohl RAI de Vos K Del Tredici Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons Acta Neuropathol 113 2007 421 429
43. A Minguez-Castellanos CE Chamorro F Escamilla-Sevilla Do α-synuclein aggregates in autonomic plexuses predate Lewy body disorders? A cohort study Neurology 68 2007 2012 2018
44. WP Gai PC Blumbergs LB Geffen WW Blessing Age-related loss of dorsal vagal neurons in Parkinson’s disease Neurology 42 1992 2106 2111
45. H Braak U Rüb WP Gai K Del Tredici Idiopathic Parkinson’s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen J Neural Transm 110 2003 517 536
46. Phillips RJ, Walter GC, Wilder SL, Baronowski EA, Powley TL. Alpha-synuclein immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson’s disease? Neuroscience Epub 2008 Mar 18.
47. K Del Tredici H Braak A not entirely benign procedure: progression of Parkinson’s disease Acta Neuropathol 115 2008 379 384
48. K Wakabayashi H Takahashi E Ohama S Takeda F Ikuta Lewy bodies in the visceral autonomic nervous system in Parkinson’s disease Adv Neurol 60 1993 609 612
49. K Wakabayashi H Takahashi Neuropathology of autonomic nervous system in Parkinson’s disease Eur Neurology 38 suppl 2 1997 2 7
50. M Palka-Santini B Schwarz-Henke M Hösel The gastrointestinal tract as the portal of entry for foreign macromolecules: fate of DANN and proteins Mol Genet Genom 270 2003 201 215
51. L Rinaman P Levitt JP Card Progressive postnatal assembly of limbic-autonomic circuits revealed by central transneuronal transport of pseudorabies virus J Neurosci 20 2000 2731 2741
52. S Orimo T Amino Y Itoh Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease Acta Neuropathol 109 2005 583 588
53. S Orimo A Takahashi T Uchihara Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson’s disease Brain Pathol 17 2007 24 30
54. RD Abbott H Petrovitch LR White Frequency of bowel movements and the future risk of Parkinson’s disease Neurology 57 2001 456 462
55. MF Siddiqui S Rast MJ Lynn AP Auchus RF Pfeiffer Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey Parkinsonism Relat Disord 8 2002 277 284
56. RF Pfeiffer Gastrointestinal dysfunction in Parkinson’s disease Lancet Neurol 2 2003 107 116
57. H Kaufmann K Nahm D Purohit D Wolfe Autonomic failure as the initial manifestation of Parkinson’s disease and dementia with Lewy bodies Neurology 63 2004 1093 1095
58. EE Benarroch Pain: autonomic interactions: a selective review Clin Auton Res 11 2001 343 349
59. JI Sage Pain in Parkinson’s disease Curr Treat Options Neurol 6 2004 191 200
60. E Scherder E Wolters C Polman J Serfeant D Swaab Pain in Parkinson’s disease and multiple sclerosis: Its relation to the medial and lateral pain systems Neurosci Biobehav Rev 29 2005 1047 1056
61. BF Boeve MH Silber CB Saper Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease Brain 69 2007 2770 2788
62. U Rüb K Del Tredici C Schultz Parkinson’s disease: The thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology Neurobiol Aging 23 2002 245 254
63. HI Hurtig JQ Trojanowski J Galvin Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease Neurology 54 2000 1916 1921
64. H Apaydin E Ahlskog JE Parisi BF Boeve DW Dickson Parkinson disease neuropathology Arch Neurol 59 2002 102 112
65. H Braak M Sastre K Del Tredici Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease Acta Neuropathol 114 2007 231 241
66. Duda JE, Noorigian JV, Petrovitch H, White LR, Ross GW. Pattern of Lewy pathology progression suggested by Braak staging system is supported by analysis of a population-based cohort of patients. The Mov Disord Society’s 11th International Congress Late Breaking Abstracts 2007;A3.
67. GM Halliday H McCann Human-based studies on alpha-synuclein deposition and relationship to Parkinson’s disease symptoms Exp Neurol 209 2008 12 21
68. L Parkkinen T Kauppinen T Pirttila JM Autere I Alafuzoff Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia Ann Neurol 57 2005 82 91
69. L Parkkinen T Pirttilä I Alafuzoff Applicability of current staging systems of α-synuclein pathology and their clinical relevance Acta Neuropathol 115 2008 399 407
70. KA Jellinger α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution: a pilot study Acta Neuropathol 106 2003 191 201
71. L Parkkinen H Soininen I Alafuzoff Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer’s disease J Neuropathol Exp Neurol 62 2003 363 367
72. H Uchikado WL Lin MW DeLucia DW Dickson Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy J Neuropathol Exp Neurol 65 2006 685 697
73. G Halliday M Hely W Reid J Morris The progression of pathology in longitudinally-followed patients with Parkinson’s disease Acta Neuropathol 115 2008 409 415
74. O Rascol P Payoux F Ory JJ Ferreira C Brefel-Courbon JL Montastruc Limitations of current Parkinson’s disease therapy Ann Neurol 53 suppl 3 2003 3 15
75. CH Adler Nonmotor complications in Parkinson’s disease Mov Disord 20 suppl 11 2005 23 29
76. KR Chaudhuri DG Healy AH Schapira Non-motor symptoms of Parkinson’s disease: diagnosis and management Lancet Neurol 5 2006 235 245